Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Join us on Tuesday 4 June for an exclusive drinks reception and panel event featuring some of the UK’s top former and current sports professionals living with type 1 diabetes.
Find out about the latest progress in type 1 diabetes research, learn more about our ongoing partnerships or see what our celebrity ambassadors are up to.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D. Every pound raised directly supports us to fund our life-changing research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > For professionals > Policymakers
At Breakthrough T1D, we are dedicated to making a positive impact on the lives of everyone living with type 1 diabetes by actively participating in advocacy work. Explore our position statements, policy briefings and reports and resources.
Our goal is to shape healthcare consultations regarding access to new treatments and technology. You can learn more about our efforts in influencing policies that affect people with type 1 by exploring our comprehensive policy papers.
A crucial aspect of our work involves actively engaging and responding to consultations from public bodies such as the National Health Service (NHS), the National Institute for Health and Care Excellence (NICE), and the UK and Devolved Governments.
We contribute real-life case studies, gather insights from academic experts and healthcare professionals, ensuring that the unique needs and challenges of people with type 1 diabetes are taken into account when making healthcare decisions and developing guidelines.
We regularly publish our policy positions on key issues related to type 1 diabetes. These positions are based on expert research, input from the type 1 community, and the valuable insights provided by individuals and professionals in the field. By making our positions publicly available, we aim to raise awareness and advocate for necessary changes that will enhance the lives of everyone living with type 1 diabetes.
We actively engage in efforts to influence government policies through briefings and meetings with Parliamentarians. By working closely with policymakers, we strive to ensure that the concerns and voices of the type 1 diabetes community are heard and addressed.
Through strategic advocacy, we aim to drive policy changes that enhance access to innovative treatments, support research funding, and improve overall healthcare for all individuals with type 1 diabetes.
Read how Breakthrough T1D gives information and evidence to policymakers and healthcare bodies to inform policies, debates, and laws relating to type 1 diabetes.
View and download our reports and resources that can help you to make type 1 diabetes a priority for policymakers and healthcare professionals.
Read Breakthrough T1D’s position on a range of issues including our position regarding animal research, telemedicine, access to type 1 technology, and ‘DIY’ technologies.
Our international research programme means that life-changing treatments and developments for type 1 diabetes are in clinical trials around the world.
We commissioned social research to understand the varying pandemic experiences of different people affected by type 1 diabetes in the UK. The experiences shared for the report depict an enormous withdrawal of NHS services during the pandemic, leading to starkly unequal access to type 1 diabetes care.
Novo Nordisk will stop producing Levemir insulin next year but there are plans in place to help you transition to an alternative.
A new paper co-authored by Breakthrough T1D, Diabetes UK, and Kidney Research UK has identified six themes to tackle diabetic kidney disease.
Our highlights from a year full of breakthroughs in type 1 diabetes research and advocacy.
The framework aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
